
Ireland - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Ireland: Medicaments Containing Insulin Market 2023
Medicaments Containing Insulin Market Size in Ireland
The Irish medicaments containing insulin market reduced remarkably to $X in 2022, with a decrease of X% against the previous year. In general, consumption recorded a deep contraction. Medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.
Medicaments Containing Insulin Production in Ireland
In value terms, medicaments containing insulin production amounted to less than $X in 2022 estimated in export price. Over the period under review, production showed a sharp setback. The growth pace was the most rapid in 2015 with a decrease of X% against the previous year. Over the period under review, production reached the maximum level at $X in 2014; however, from 2015 to 2022, production stood at a somewhat lower figure.
Medicaments Containing Insulin Exports
Exports from Ireland
Medicaments containing insulin exports from Ireland amounted to X kg in 2022, remaining stable against 2021. Overall, exports showed a pronounced reduction. The smallest decline of X% was in 2021. The exports peaked at X kg in 2020; however, from 2021 to 2022, the exports failed to regain momentum.
In value terms, medicaments containing insulin exports amounted to $X in 2022. In general, exports recorded a sharp shrinkage. The smallest decline of X% was in 2021. The exports peaked at $X in 2020; however, from 2021 to 2022, the exports remained at a lower figure.
Exports by Country
The UK (X kg) was the main destination for medicaments containing insulin exports from Ireland, accounting for a X% share of total exports. It was followed by the Netherlands (X kg), with a X% share of total exports.
From 2020 to 2022, the average annual rate of growth in terms of volume to the UK was relatively modest.
From 2020 to 2022, the average annual growth rate of value to the UK was relatively modest.
Export Prices by Country
The average medicaments containing insulin export price stood at $X per ton in 2022, stabilizing at the previous year. Over the period under review, the export price faced a dramatic downturn. The growth pace was the most rapid in 2021 a decrease of X% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2020; however, from 2021 to 2022, the export prices remained at a lower figure.
There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to the Netherlands stood at $X per ton.
From 2020 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the Netherlands (X%).
Medicaments Containing Insulin Imports
Imports into Ireland
In 2022, overseas purchases of medicaments containing insulin but not antibiotics decreased by X% to X kg, falling for the third year in a row after four years of growth. Overall, imports saw a dramatic contraction. The most prominent rate of growth was recorded in 2019 when imports increased by X%. Imports peaked at X tons in 2012; however, from 2013 to 2022, imports stood at a somewhat lower figure.
In value terms, medicaments containing insulin imports plummeted to $X in 2022. Over the period under review, imports recorded a deep reduction. The pace of growth appeared the most rapid in 2018 when imports increased by X%. Over the period under review, imports hit record highs at $X in 2019; however, from 2020 to 2022, imports failed to regain momentum.
Imports by Country
In 2022, France (X kg) constituted the largest supplier of medicaments containing insulin to Ireland, with a X% share of total imports. Moreover, medicaments containing insulin imports from France exceeded the figures recorded by the second-largest supplier, Romania (X kg), fivefold.
From 2012 to 2022, the average annual rate of growth in terms of volume from France was relatively modest. The remaining supplying countries recorded the following average annual rates of imports growth: Romania (X% per year) and the UK (X% per year).
In value terms, France ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Ireland, comprising X% of total imports. The second position in the ranking was taken by Romania ($X), with a X% share of total imports.
From 2012 to 2022, the average annual rate of growth in terms of value from France was relatively modest. The remaining supplying countries recorded the following average annual rates of imports growth: Romania (X% per year) and the UK (X% per year).
Import Prices by Country
In 2022, the average medicaments containing insulin import price amounted to $X per ton, which is down by X% against the previous year. In general, the import price, however, recorded a noticeable expansion. The pace of growth appeared the most rapid in 2018 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2019 to 2022, the average import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Romania ($X per ton), while the price for the UK ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Romania (X%), while the prices for the other major suppliers experienced a decline.
Source: IndexBox Platform
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2022 | 2012-2022 | 2023-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in Ireland. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
-
MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
- 7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- 8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2022
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
- 9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2022
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
-
LIST OF TABLES
- Key Findings In 2022
- Market Volume, In Physical Terms, 2012–2022
- Market Value, 2012–2022
- Per Capita Consumption In 2012-2022
- Imports, In Physical Terms, By Country, 2012–2022
- Imports, In Value Terms, By Country, 2012–2022
- Import Prices, By Country Of Origin, 2012–2022
- Exports, In Physical Terms, By Country, 2012–2022
- Exports, In Value Terms, By Country, 2012–2022
- Export Prices, By Country Of Destination, 2012–2022
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2022
- Market Value, 2012–2022
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2022
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2022
- Trade Balance, In Physical Terms, 2012-2022
- Trade Balance, In Value Terms, 2012-2022
- Per Capita Consumption, 2012-2022
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2022
- Production, In Value Terms, 2012–2022
- Imports, In Physical Terms, 2012–2022
- Imports, In Value Terms, 2012–2022
- Imports, In Physical Terms, By Country, 2022
- Imports, In Physical Terms, By Country, 2012–2022
- Imports, In Value Terms, By Country, 2012–2022
- Import Prices, By Country Of Origin, 2012–2022
- Exports, In Physical Terms, 2012–2022
- Exports, In Value Terms, 2012–2022
- Exports, In Physical Terms, By Country, 2022
- Exports, In Physical Terms, By Country, 2012–2022
- Exports, In Value Terms, By Country, 2012–2022
- Export Prices, By Country Of Destination, 2012–2022
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the global medicaments containing insulin market.